Clinical trials requiring participants with kidney impairment
At Nucleus Network in Minneapolis, we are always looking for clinical trial participants with kidney impairment. You will be reimbursed for your time, and you can help advance medicine & improve lives.
At the Nucleus Network clinic in Minneapolis/St. Paul we specialize in clinical trials with people who have kidney disease. We perform these trials in collaboration with Kidney Specialists of Minnesota, and we also have our own team of medical experts.
These clinical trials play a vital role in the development of new medication. They play an essential role in ensuring that people with kidney impairment receive the correct dose of medication. We are always looking for new participants!
Benefits of taking part in one of our clinical trials include:
- We compensate participants up to $350 per day for their time
- High-end medical care and free medical monitoring throughout each trial
- You will have access to WiFi, TVs, games, and we provide free, tasty meals during your stay at the clinic
- The knowledge that you are helping to advance medicine and improve lives. The trials that we conduct play an important role in the development of new medication
Does this sound like something for you (or somebody you know)? Please give us a call on 612-315-6490 or have a look at our current studies below (direct recruitment line).
- Study name
- Eligibility
- Status
- Overnight stays
- Outpatient visits
- Study name AXS-05-113 StudyEligibility
- Age: 18-80
- BMI: 18.5-40.0 kg/m2
- Medications: Approved on case-by-case basis.
- Compensation: up to $6,850
- Smoking Status: non-smokers or smokers must agree to consume no more than 10 cigarettes or equivalent/day during the study treatment period.
- Medical History: Severe renal impairment
Status Currently RecruitingOvernight stays 10 nightsOutpatient visits 1 visits
- Study name Renal StudyEligibility
- Age: 18-85
- BMI: 19.0 - 40.0 kg/m2
- Medication: Medications must be stable for at least 2 weeks before the screening visit and will need to remain stable until the last PK sample of the study.
- Smoking: No more than 5 cigarettes per day while inpatient and no more than 10 cigarettes (or equivalent) per day before the study
- Compensation: Up to $4,600.00
- Dose Administration: subcutaneous
Status Currently RecruitingOvernight stays 5 nightsOutpatient visits 4 visits
- Study name COVID Treatment StudyEligibility
- Age: 18-80
- BMI: 18.5-38 kg/m2
- Medication: A stable medication regimen is required, defined as not starting new drug(s) or changing dosage(s) within 14 days prior to administration of study intervention
- Compensation: up to $5,600
- Smoking status: If the participant smokes tobacco, the participant must agree to smoke no more than 10 cigarettes per day from study entry until the Follow-up/Early Termination visit.
Status Currently RecruitingOvernight stays 15 nightsOutpatient visits 2 visits
- Study name Glycemic Control StudyEligibility
- Age: >18
- BMI: 17.5-45.4 kg/m2
- Medications: Stable concomitant medications for the management of medical conditions relevant to an individual participant’s medical history.
- Compensation: up to $3,022 for study completion
- Smoking history: Abstain from use of tobacco- or nicotine-containing products for a minimum of 2 hours before all vital signs and ECG measurements, and for a minimum of 2 hours before and after study drug dosing.
Status Currently RecruitingOvernight stays 7 nightsOutpatient visits 3 visits